A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

Chang TT, Gish RG, de Man R, et al. N Engl J Med. 2006;354:1001-1010.

Capsule Summary | Abstract | Slides

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

Lai CL, Shouval D, Lok AS, et al. N Engl J Med. 2006;354:1011-1020.

Capsule Summary | Abstract | Slides

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.

Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Gastroenterology. 2006;130:678-686.

Capsule Summary | Abstract | Slides

Click here to access more Journal Options for Hepatitis

Milan 2008

Update on Hepatitis B Management

Highlight on Special Hepatic Issues and Populations

Boston 2007

Highlight on Special Hepatic Issues and Populations

Clinical Updates in HBV Treatment

Washington 2007

New Data on Viral Hepatitis and Related Complications

Barcelona 2007

Advances in HBV Treatment: 2007

Highlight on Special Hepatic Issues and Populations

Boston 2006

Clinical Updates in HBV Treatment

Los Angeles 2006

New Data on Viral Hepatitis and Related Complications

HBV Workshop 2006

2006 Update on Hepatitis B Management

Vienna 2006

Updates in HBV Management

Shanghai 2006

New Developments in the Management of Chronic Hepatitis B

Hawaii 2005

Conference Report

San Francisco 2005

HCV Management: Facing New Challenges

Managing HCC and Liver Transplantation

Latest Findings in HBV Management

Bali 2005

New Data on Chronic Hepatitis B